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Abstract
Background: This study compares Mycobacterium tuberculosis culture isolation and drug sensitivity testing (DST)
using solid (LJ) and liquid (BACTEC-MGIT-960) media in Nigeria.
Methods: This was a cross sectional survey of adults attending reference centres in Abuja, Ibadan and Nnewi with
a new diagnosis of pulmonary tuberculosis (TB) or having failed the first-line TB treatment. Patients were requested
to provide three sputum specimens for smear-microscopy and culture on LJ and BACTEC-MGIT-960. Positive
cultures underwent DST for streptomycin, isoniazid, rifampicin and ethambutol.
Results: 527 specimens were cultured. 428 (81%) were positive with BACTEC-MGIT-960, 59 (11%) negative, 36 (7%)
contaminated and 4 (1%) had non-tuberculosis mycobacteria (NTM). 411 (78%) LJ cultures were positive, 89 (17%)
negative, 22 (4%) contaminated and 5 (1%) had NTM. The mean (SD) detection time was 11 (6) and 30 (11) days for
BACTEC-MGIT-960 and LJ. DST patterns were compared in the 389 concordant positive BACTEC-MGIT-960 and LJ
cultures. Rifampicin and isoniazid DST patterns were similar. Streptomycin resistance was detected more frequently
with LJ than BACTEC-MGIT-960 and ethambutol resistance was detected more frequently with BACTEC-MGIT-960
than LJ, but differences were not statistically significant. MDR-TB was detected in 27 cases by LJ and 25 by BACTEC-
MGIT-960 and using both methods detected 29 cases.
Conclusions: There was a substantial degree of agreement between the two methods. However using the two in
tandem increased the number of culture-positive patients and those with MDR-TB. The choice of culture method
should depend on local availability, cost and test performance characteristics.
Keywords: Multi-drug resistant tuberculosis, First-line anti-TB drugs, Solid culture, Liquid culture, Drug sensitivity
Background
Culture of Mycobacterium tuberculosis complex (MtbC)
is the accepted reference standard for confirmation of
TB infection and is necessary for drug susceptibility test-
ing (DST). There are several methods for culturing MtbC
using solid and liquid media. Although solid media has
been used for over 100 years, liquid culture media is in-
creasingly being introduced in low and middle income
countries (LMIC). Solid culture media is cheaper and
more widely available, but is labour-intensive, less sensitive
and slower than liquid culture [1-3]. Liquid culture
systems can be automated, facilitating the processing of
large numbers of specimens, but are costly and more
prone to contamination [1]. The decision for a laboratory
to switch from solid to liquid culture therefore should be
considered carefully.
Nigeria, the most populous country in Africa, has one
of the largest burdens of TB. Clinical response to treat-
ment is often less than optimal and WHO estimates that
2.2% and 9.4% of new and re-treatment TB cases have
Multi drug resistant TB (MDR-TB), ranking 15th among
the high MDR-TB burden countries. The Nigerian TB
and Leprosy Control Programme (NTBLCP) has given
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high priority to improve the identification and treatment
of cases with MDR-TB and has recently commissioned
the development of diagnostic and treatment facilities in
referral centers across the country. DST capacity how-
ever remains limited because most of these facilities are
concentrated in large urban centers.
Despite the increasing availability of DST facilities in
West Africa, there are very few head-to-head comparisons
of the MtbC DST patterns obtained by liquid and solid sys-
tems, to inform laboratories considering whether to replace
one method for the other or to run the two in parallel.
Here we compared the DST results obtained when speci-
mens were cultured using solid (Lowenstein Jensen, LJ)
and an automated liquid culture media (BACTEC Myco-
bacterium Growth Indicator Tube (MGIT) 960).
Methods
This cross sectional study was conducted in Abuja,
Ibadan and Nnewi, in Nigeria. The aim was to compare
the isolation rate of MtbC from sputum using LJ and the
BACTEC-MGIT-960 and then compare the level of agree-
ment of DST to first-line anti-TB drugs using each type of
media. Adults (>18 years old) with sputum smear-positive
microscopy were enrolled between August 2009 and July
2010. Both newly diagnosed patients and those who had
failed first-line treatment (patients continuing to be smear-
positive after 5 months of treatment) were prospectively
enrolled until 500 new and 100 re-treatment patients were
enrolled. Patients enrolled were not receiving treatment at
the time of enrolment. Exclusion criteria included patients
unable to produce sputum or to provide informed consent
to participate and smear-negative cases. The sample sizes
were calculated to assess the prevalence of drug resistance
in new and retreatment patients, as described in Lawson
et al. [4]. Specimens considered of poor quality (salivary)
or to have a quantity insufficient for both cultures were
excluded.
Three sputum samples were submitted from each pa-
tient for direct Ziehl Neelsen smear microscopy. If the
patient was smear-positive, the best quality specimen
(defined as the most muco-purulent) was sent for cul-
ture and DST at Zankli Medical Research Laboratory
(ZMRL) in Abuja within seven days of collection. Sam-
ples were refrigerated prior to shipment and maintained
in cold-chain during shipment with ice packs. At ZMRL,
specimens were decontaminated using Petroff ’s method
(4% NAOH) and cultured on LJ and on an automated
BACTEC-MGIT-960 system (Beckton Dickinson, Franklin
Lakes, NJ) [5,6]. Two hundred microlitres of decontam-
inated sputa were inoculated on each of two glycerol
enriched LJ slopes and 500 μl in BACTEC-MGIT-960
7H9 bottles. The BACTEC 960 was enriched with supple-
ment (OADC) and antibiotics (PANTA) prior to inocula-
tion. Cultures were incubated at 37°C for up to 8 weeks
on LJ and 42 days in BACTEC-MGIT-960. LJ cultures
were checked weekly and BACTEC-MGIT-960 cultures
were monitored continuously through the automated
system. Isolates were confirmed as MtbC by ZN smear of
isolates to observe the serpentine cords typical of MtbC,
the Nitrate reduction test and temperature lability of the
catalase test. Unfortunately these were the only available
tests in the laboratory at the time of the study, as con-
firmatory tests such as MPT 64 BD ID test strips were
not available. The time to MtbC detection on LJ and
BACTEC-MGIT-960 were recorded. MGIT time to detec-
tion was defined as the interval between inoculation and
the bottle being flagged as positive by the machine. LJ
time to detection was defined as the time between inocu-
lation and the culture being considered positive by naked
eye reading.
Pure AFB cultures were tested for their sensitivity to
streptomycin (STR), isoniazid (INH), rifampicin (RIF)
and ethambutol (EMB) using the proportion method in
LJ [7,8] and in MGIT bottles in the BACTEC-MGIT-960
according to the manufacturers recommendations [5,6].
Drug concentrations in LJ and BACTEC-MGIT-960
were 8.0 and 1.0 μg/ml for STR, 0.2 and 0.1 μg/ml for
INH, 40 and 1.0 μg/ml for RIF and 2 and 1.0 μg/ml for
EMB. The agreement of the DST results obtained using
both methods were compared using Kappa statistics.
Zankli Medical Research Laboratory undergoes exter-
nal quality assurance of DST for first-line anti-TB drugs
through the WHO Supranational Reference Laboratory
Network (SRLN) for BACTEC-MGIT-960 and LJ. The
most recent EQA of the laboratory results was 100% for
STR, INH, RIF and EMB when using BACTEC-MGIT-
960; 100% for STR, RIF and EMB and 80% for INH
when using LJ.
All data were analyzed using Epi-info (CDC, 1600 Clifton
road, 1 Atlanta, GA, 30333). Proportions were compared
using Chi squared tests and the degree of agreement was
compared using the Kappa statistic. Ethical approval was
obtained from the Federal Capital Territory Health and Re-
search Ethics Committee and Zankli Ethical Research Re-
view Board. Participants provided their written informed
consent to participate, following the procedures approved
by the ethics committees.
Results
A total of 527 sputum specimens were cultured on LJ
and the BACTEC-MGIT-960. The mean (SD, range) age
of the patients was 34 (12, 7–82) years, with 315 (60%)
being male. The mean (range) time to detection was 11
(1–33) and 30 (7–56) days for BACTEC-MGIT-960 and
LJ, respectively. The results stratified by the participating
centres are shown in Table 1. In total 527 specimens
were cultured. Of these, 428 (81%) were positive with
BACTEC-MGIT-960, 59 (11%) negative, 36 (7%)
Lawson et al. BMC Research Notes 2013, 6:215 Page 2 of 5
http://www.biomedcentral.com/1756-0500/6/215
contaminated and 4 (1%) had non-tuberculosis mycobac-
teria (NTM). In comparison, 411 (78%) LJ cultures were
positive, 89 (17%) negative, 22 (4%) contaminated and 5
(1%) had NTM. The mean (SD) detection time was 11 (6)
and 30 (11) days for BACTEC-MGIT-960 and LJ.
For the purpose of the head to head comparison, only
patients examined with results for both culture systems
were included in Table 2. The LJ and BACTEC-MGIT-
960 culture results were concordant in 449 (85%) sam-
ples, with substantial agreement between the methods
(Kappa = 0.7, Standard error = 0.046). Agreement included
both cultures being positive in 389, negative in 49, con-
taminated in seven and growing NTM in four. Discordant
results included nine LJ positive/BACTEC-MGIT-960
negative, 24 LJ negative/BACTEC-MGIT-960 positive and
44 contaminated by one but not the other method. The
use of both methods allowed the identification of 58 cases
that were positive by one method but negative by the
other method. The largest proportion of additional cases
(24, 41%) was LJ culture negative and BACTEC-MGIT
-960 culture positive. Similarly, although 58 cultures were
contaminated (22 LJ and 36 BACTEC-MGIT-960), only 7
of these were contaminated by both methods. Using both
methods therefore resulted in an additional yield of cul-
tures with interpretable results.
DST was conducted on both BACTEC-MGIT-960 and
LJ media in the 389 concordant culture-positive isolates.
The DST results obtained by LJ and BACTEC-MGIT-
960 are shown in Figure 1. There were discordant results
for 16 (4.1%) RIF, 20 (5.1%) INH, 28 (7.1%) STR and 37
(9.4%) EMB results. The level of DST agreement how-
ever was high and RIF and INH had equal numbers of
discordant LJ and BACTEC results by each method
(Kappa, 0.801 and 0.866, respectively). Streptomycin re-
sistance was detected more frequently with LJ than
BACTEC-MGIT-960 (79 versus 71 cases, respectively,
Kappa 0.769) and EMB resistance was detected more
frequently with BACTEC-MGIT-960 than LJ (91 and 86
cases, respectively, Kappa 0.730), but these differences
were not statistically significant.
Twenty nine patients were classified as having MDR
by at least one of the two methods. Of these 27 were
identified by LJ and 25 by BACTEC-MGIT-960 (Kappa
0.876).
Discussion
Tuberculosis drug resistance is increasing in many
LMICs and Nigeria is not an exception [4,9,10]. Most
National TB control programmes (NTP) are strengthen-
ing their capacity for the treatment of MDR-TB, but des-
pite these steps many patients are unconfirmed because
relatively few centres are equipped or have the resources
to conduct DST [11].
NTPs often need to decide on the culture method that
should be implemented in the country. Among the as-
pects that need to be considered are the sensitivity of
the method and its susceptibility to contamination. The
higher sensitivity of liquid over solid culture is widely ac-
cepted [12] and accordingly, in this study BACTEC-
MGIT-960 was more often positive than LJ. Similarly,
BACTEC-MGIT-960 often has higher contamination
rates than LJ; a problem often reported from LMICs
[1,2,12-14], and we also had a higher frequency of con-
tamination in liquid culture.
Services should also be aware of the delay of both cul-
ture methods which affect clinical management. Al-
though this delay is more prolonged with LJ, it is still
significant with liquid culture and clinical decisions are
often made before culture and DST results are available
for both methods [15].
Table 1 Culture results from BACTEC960 and LJ media by study site
Abuja Ibadan Nnewi All
BACTEC960 LJ BACTEC960 LJ BACTEC960 LJ BACTEC960 LJ
Positive 160 (80%) 156 (78%) 85 (94%) 79 (88%) 183 (77%) 176 (74%) 428 (81%) 411 (78%)
Negative 23 (12%) 35 (17%) 2 (2%) 7 (8%) 34 (14%) 47 (20%) 59 (11%) 89 (17%)*
Non tuberculous Mycobacteria 2 (1%) 2 (1%) 0 (0) 0 (0) 2 (1%) 3 (1%) 4 (1%) 5 (1%)
Contaminated 15 (7%) 7 (4%) 3 (3%) 4 (4%) 18 (8%) 11 (5%) 36 (7%) 22 (4%)**
Total 200 200 90 90 237 237 527 527
* Comparison of BACTEC-MGIT-960 and LJ, p < 0.01; ** p = 0.079.
Table 2 Culture results of sputum cultured on both LJ
and BACTEC-MGIT-960 system (only patients with both
culture results are included)
LJ
Bactec Positive Negative Contaminated NTM
Positive 389 24 14 0
Negative 9 49 1 0
Contaminated 11 17 7 1
NTM 0 0 0 4
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Liquid culture has been reported to detect more cases
of first-line drug resistance than LJ by some [16] but not
all studies, while others report a higher recovery rate of
MTbC but similar sensitivity to LJ to detect drug resis-
tance [3,17]. In conformity with the latter studies, we
obtained a higher sensitivity of liquid culture but a high
agreement between the two DST methods. The agreement
was lower for STR and EMB than for RIF and INH. Al-
though these could be due to methodological errors, our
laboratory participates in an international external quality
assurance system and it is likely discordant results reflect
discordances of the methods, and not staff mistakes, as
observed in other settings. The issue of DST discordance
was the topic of a recent WHO expert group meeting,
where discussion centered on whether the appropriate
breakpoints were being used for some of the drugs (http://
www.who.int/tb/challenges/xdr/xdrconsultation/en/index.
html). If the results of both methods were considered
valid, these discrepancies would result in the identification
of a higher number of drug resistant strains with impor-
tant cost and patient care implications. This is thus an
area that requires further research.
Another consideration for choosing solid or liquid cul-
ture is the cost of the systems and the availability of con-
sumables. Liquid culture is several times more expensive
than solid media and although consumables for LJ media
are universally available in Nigeria, there is only one
supplier for BACTEC-MGIT-960 and we have experi-
enced difficulties maintaining stocks. The test perform-
ance characteristics, its overall cost and availability
therefore have important implications for deciding the
DST method of choice in a country. In our context, and
in other settings with limited resources, laboratories
should be encouraged to develop solid culture capability
and to add liquid culture only when the resources re-
quired become available.
The study reported here has several limitations. We
only included patients with smear-positive disease and
excluded smear-negative cases. This was based on the al-
gorithm for testing in Nigeria, in which patients with
smear-negative results are not routinely cultured. Smear-
negative but culture-positive patients however would
benefit from DST and it is possible that their exclusion
could lead to some bias. This bias could be due to the
yield of culture (as liquid culture may be more sensitive
in smear-negative patients) and the performance of DST,
as patients with paucibacillary TB or milder forms of the
disease could have different DST patterns than those
with high bacillary loads.
Conclusion
In conclusion, liquid culture is more sensitive than solid
culture, but there was a high degree of agreement be-
tween the two systems. Their simultaneous use resulted
in a higher recovery rate and detection of more drug re-
sistance than using only one of the two methods. The
mean time to detection was shorter with liquid culture
and its monitoring can be automated to facilitate dealing
with large number of specimens. However this method
is more costly and prone to contamination [1]. Solid and
liquid culture had high levels of agreement for detecting
drug resistance. Given its lower risk of contamination,
costs and availability, the LJ method may be preferable
in LMIC settings with limited resources and most labora-
tories introducing liquid culture systems should maintain
solid culture until the method is well established.
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Figure 1 DST agreement among patients with concordant positive BACTEC-MGIT-960 and LJ cultures.
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